Adhesive guaze
Adhesive gauze dressings with pharmaceutical coating
HSN 3005 10 10 (Adhesive gauze) is subject to the Drugs and Cosmetics Act, 1940, which governs the import of pharmaceutical-grade wound-care articles put up for retail sale for medical or surgical purposes. Three mandatory documents — Certificate of Analysis, Batch Release Certificate, and consignment label — must be uploaded in e-Sanchit before customs out-of-charge. No separate import licence number is cited in the operative compliance record, but document verification at the bill-of-entry stage is the binding clearance requirement.
- Certificate of Analysis from manufacturer
- Batch Release Certificate from manufacturer
- Label of consignment from importer
- 1Ensure the Certificate of Analysis for the drug/pharmaceutical-grade adhesive gauze (document code 0010dc) and the Batch Release Certificate (document code 0030dc) are obtained from the foreign manufacturer and uploaded in e-Sanchit before filing the bill of entry. Customs out-of-charge will not be granted without these uploads.e-Sanchit mandatory documents — document codes 0010dc, 0030dc per CCR
- 2Upload the consignment label (document code 0110dc) in e-Sanchit at the bill of entry. The label must comply with the applicable pharmaceutical-product labelling requirements; the proper officer will verify all three documents prior to issuing out-of-charge.e-Sanchit mandatory documents — document code 0110dc per CCR
The most frequent error on this tariff line is treating adhesive gauze as a general medical consumable and filing without the pharmaceutical-grade document set. Because the article is impregnated or coated with pharmaceutical substances and put up for retail medical use, it falls within the drug-product documentation regime: a missing or mismatched Batch Release Certificate (0030dc) or Certificate of Analysis (0010dc) results in consignment detention at the port pending PGA facilitation, with attendant demurrage and ground rent liability.